Tissue and tumor atlases revolutionize our understanding of disease progression and therapeutic response. They provide precise molecular data on cell types, states, and interactions in a preserved 3D environment to improve diagnosis and disease management.

Navigating Spatial Biology

The Harvard Tissue Atlas (HTA) gathers image and -omic datasets into high-resolution molecular maps. Our atlases provide precise molecular data on cell types, states, and interactions in a preserved 3D environment, shedding light on the complex interactions between cellular and acellular structures in normal and diseased tissue. These data provide a deeper understanding of how diseases start and progress to improve disease diagnosis and management.

The Harvard Tissue Atlas datasets enable a foundation for future advances in precision medicine, such as early cancer detection, AI/ML predictive models, and disease stratification for clinical trials.

More

Atlases

Thumbnail image for news item
Melanoma Pre-Cancer and Progression Atlas
Atlas
Thumbnail image for news item
BRCA-positive Breast Cancer Atlas
Atlas
Thumbnail image for news item
Colorectal Cancer Atlas
Atlas
Thumbnail image for news item
Ludwig Tumor Atlas: A Focus on Drug Resistance
Atlas

News

Thumbnail image for news item
Advancing strategies to combat BRCA-linked cancer threats
Spring 2025. Pulse
News
Thumbnail image for news item
Clues to catching a deadly cancer early.
2025. Ludwig Cancer Research
News
Thumbnail image for news item
Understanding the earliest stages of ovarian cancer.
HMS News 2025. LinkedIn
News
Thumbnail image for news item
New Therapeutic Strategy Identified for Triple Negative Breast Cancer
2024, October 9. BWH Research Brief
News

Publications & Software

Thumbnail image for news item
Multimodal spatial profiling reveals immune suppression and microenvironment remodeling in fallopian tube precursors to high-grade serous ovarian carcinoma.
Kader et al 2025. Cancer Discovery
Explore Data Publication
Thumbnail image for news item
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution
Schade, Perurena, Yang, et al 2024. Nature.
Publication
Thumbnail image for news item
Ovarian cancer-derived IL-4 promotes immunotherapy resistance
Mollaoglu, Tepper, et al. 2024. Cell
Publication
Thumbnail image for news item
Development and validation of time-to-event models to predict metastatic recurrence of localized cutaneous melanoma
Wan, Leung, et al. 2024. J Am Acad Dermatol
Publication

Featured Data Explorations

Data image
Clear Cell Odontogenic Carcinoma (IF)
Data image
Ovarian STIC Spatial Transcriptomic Data from GeoMX and Multiplex Imaging
Data image
Nuclear envelope atypia and rupture in human glioblastoma
Data image
Multimodal spatial profiling of colorectal cancer using Orion
Data image
Graphical Abstract - Multiplexed 3D atlas of state transitions and immune interactions in colorectal cancer
Data image
Exploring the Stages of Tuberculosis Granulomas
Data image
Deep Exploration of a Primary Melanoma (MEL 1 Full Story)
Data image
Patient 2 - Melanoma in situ, invasive melanoma, precursor field and inflammatory regression